Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value: $3.637B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 21,751,284 | $1.093B | 30.0% | — | — | CLASS A ORD | 61559X104 |
| KYMR | KYMERA THERAPEUTICS INC | 5,161,801 | $208M | 5.7% | — | — | COM | 501575104 |
| RVMD | REVOLUTION MEDICINES INC | 5,981,212 | $193M | 5.3% | — | — | COM | 76155X100 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 3,922,413 | $125M | 3.4% | — | — | COM | 35104E100 |
| GHRS | GH RESEARCH PLC | 10,400,158 | $111M | 3.0% | — | — | ORDINARY SHARES | G3855L106 |
| JANX | JANUX THERAPEUTICS INC | 2,919,818 | $110M | 3.0% | — | — | COM | 47103J105 |
| MIRM | MIRUM PHARMACEUTICALS INC | 4,370,024 | $110M | 3.0% | — | — | COM | 604749101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 3,755,990 | $109M | 3.0% | — | — | COM | 74366E102 |
| IONS | IONIS PHARMACEUTICALS INC | 2,428,613 | $105M | 2.9% | — | — | COM | 462222100 |
| OLMA | OLEMA PHARMACEUTICALS INC | 9,135,893 | $103M | 2.8% | — | — | COM | 68062P106 |
| KURA | KURA ONCOLOGY INC | 4,786,293 | $102M | 2.8% | — | — | COM | 50127T109 |
| XOMA | XOMA CORP DEL | 3,633,743 | $87.39M | 2.4% | — | — | COM NEW | 98419J206 |
| CGON | CG ONCOLOGY INC | 1,884,191 | $82.72M | 2.3% | — | — | COM | 156944100 |
| TYRA | TYRA BIOSCIENCES INC | 4,661,194 | $76.44M | 2.1% | — | — | COM | 90240B106 |
| — | ESSA PHARMA INC | 8,748,629 | $74.28M | 2.0% | — | — | COM NEW | 29668H708 |
| ZYME | ZYMEWORKS INC | 5,870,000 | $61.75M | 1.7% | — | — | COM | 98985Y108 |
| GLPG | GALAPAGOS NV | 1,863,809 | $60.01M | 1.6% | — | — | SPON ADR | 36315X101 |
| CGEM | CULLINAN ONCOLOGY INC | 3,196,701 | $54.47M | 1.5% | — | — | COM | 230031106 |
| — | MERUS N V | 1,172,249 | $52.79M | 1.5% | — | — | COM | N5749R100 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,162,306 | $51M | 1.4% | — | — | COM | 45166A102 |
| ANNX | ANNEXON INC | 7,000,000 | $50.19M | 1.4% | — | — | COM | 03589W102 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $48.67M | 1.3% | — | — | COM | 760273102 |
| — | 89BIO INC | 4,047,354 | $47.11M | 1.3% | — | — | COM | 282559103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,875,000 | $44.63M | 1.2% | — | — | COM | 87164F105 |
| ACIU | AC IMMUNE SA | 14,571,236 | $43.13M | 1.2% | — | — | SHS | H00263105 |
| — | THIRD HARMONIC BIO INC | 4,365,933 | $41.21M | 1.1% | — | — | COM | 88427A107 |
| ENGN | ENGENE HOLDINGS INC | 2,251,037 | $38.16M | 1.0% | — | — | COM | 29286M105 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 1,521,948 | $35.99M | 1.0% | — | — | ORDINARY SHARES | N62509109 |
| GPCR | STRUCTURE THERAPEUTICS INC | 812,988 | $34.84M | 1.0% | — | — | SPONSORED ADS | 86366E106 |
| ROIV | ROIVANT SCIENCES LTD | 2,742,409 | $28.9M | 0.8% | — | — | SHS | G76279101 |
| — | GLYCOMIMETICS INC | 9,544,262 | $28.63M | 0.8% | — | — | COM | 38000Q102 |
| TCRX | TSCAN THERAPEUTICS INC | 2,989,474 | $23.74M | 0.7% | — | — | COM | 89854M101 |
| — | ALLAKOS INC | 16,552,417 | $20.86M | 0.6% | — | — | COM | 01671P100 |
| VSTM | VERASTEM INC | 1,685,219 | $19.89M | 0.5% | — | — | COM NEW | 92337C203 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $16.24M | 0.4% | — | — | SPONSERED ADS | 13124Q106 |
| CTMX | CYTOMX THERAPEUTICS INC | 6,595,801 | $14.38M | 0.4% | — | — | COM | 23284F105 |
| — | ELEVATION ONCOLOGY INC | 2,312,200 | $11.86M | 0.3% | — | — | COM | 28623U101 |
| OVID | OVID THERAPEUTICS INC | 3,853,818 | $11.75M | 0.3% | — | — | COM | 690469101 |
| IMUX | IMMUNIC INC | 8,902,972 | $11.75M | 0.3% | — | — | COM | 4525EP101 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,000,000 | $10.56M | 0.3% | — | — | COM | 92840H400 |
| ELDN | ELEDON PHARMACEUTICALS INC | 4,326,710 | $8.913M | 0.2% | — | — | COM | 28617K101 |
| — | VERVE THERAPEUTICS INC | 650,000 | $8.632M | 0.2% | — | — | COM | 92539P101 |
| — | IKENA ONCOLOGY INC | 4,769,164 | $6.772M | 0.2% | — | — | COM | 45175G108 |
| — | CIDARA THERAPEUTICS INC | 6,861,127 | $6.312M | 0.2% | — | — | COM | 171757107 |
| — | VIGIL NEUROSCIENCE INC | 1,813,633 | $6.184M | 0.2% | — | — | COM | 92673K108 |
| DCTH | DELCATH SYS INC | 1,202,067 | $5.734M | 0.2% | — | — | COM NEW | 24661P807 |
| — | UNICYCIVE THERAPEUTICS INC | 3,611,601 | $4.984M | 0.1% | — | — | COM | 90466Y103 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $4.916M | 0.1% | — | — | *W EXP 10/31/202 | 29286M113 |
| SABS | SAB BIOTHERAPEUTICS INC | 917,826 | $4.167M | 0.1% | — | — | COM NEW | 78397T202 |
| LXRX | LEXICON PHARMACEUTICALS INC | 1,686,924 | $4.049M | 0.1% | — | — | COM NEW | 528872302 |
| ANTX | AN2 THERAPEUTICS INC | 1,239,470 | $4.028M | 0.1% | — | — | COM | 037326105 |
| — | KRONOS BIO INC | 2,905,043 | $3.777M | 0.1% | — | — | COM | 50107A104 |
| — | PIERIS PHARMACEUTICALS INC | 20,609,863 | $3.776M | 0.1% | — | — | COM | 720795103 |
| — | VIRACTA THERAPEUTICS INC | 3,614,662 | $3.687M | 0.1% | — | — | COM | 92765F108 |
| IVA | INVENTIVA SA | 686,040 | $2.483M | 0.1% | — | — | ADS | 46124U107 |
| — | FORTE BIOSCIENCES INC | 2,982,105 | $2.09M | 0.1% | — | — | COM | 34962G109 |
| MOLN | MOLECULAR PARTNERS AG | 443,221 | $1.72M | 0.0% | — | — | ADS | 60853G106 |
| — | MOLECULAR TEMPLATES INC | 522,238 | $1.17M | 0.0% | — | — | COM NEW | 608550208 |
| — | NLS PHARMACEUTICS LTD | 5,747,126 | $1.045M | 0.0% | — | — | SHS | H57830103 |
| — | ASLAN PHARMACEUTICALS LTD | 1,049,999 | $646K | 0.0% | — | — | SPON ADS NEW | 04522R200 |
| CRVS | CORVUS PHARMACEUTICALS INC | 361,406 | $643K | 0.0% | — | — | COM | 221015100 |
| RZLT | REZOLUTE INC | 190,815 | $487K | 0.0% | — | — | COM NEW | 76200L309 |